Skip to main content
. 2011 Aug 17;3:287–294. doi: 10.2147/CMR.S22717

Table 3.

Univariate analysis of brain metastases side

Metastasis side P χ2 test

Right (N) Left (N) Bilateral (N)
Patient-related variables
Sex
Male/female 11/1 9/0 15/3 0.546
Age
Mean ± SD 57.7 ± 8.3 62.6 ± 9.9 61.9 ± 8.7 0.349a
Pack-years
Mean ± SD 80.8 ± 20.2 84.0 ± 19.6 68.6 ± 26.8 0.202a
COPD
No/yes 6/6 5/4 10/8 1.000
Arterial hypertension
No/yes 10/2 4/5 7/11 0.050
Coronary disease
No/yes 12/0 9/0 13/5 0.054
Diabetes mellitus
No/yes 11/1 9/0 14/4 0.406
Gastritis/ulcer
No/yes 12/0 7/2 17/1 0.216
Hypothyroidism
No/yes 12/0 6/3 15/3 0.063
Other comorbidity
No/yes 11/1 7/2 15/3 0.740
Disease-related variables
Histotype
Non-differentiated NSCLC 6 2 7 0.194
Squamous 2 4 5
Adenocarcinoma 3 3 6
Large cell carcinoma 1 0 0
Location
Central/peripheral 10/2 8/1 15/3 1.000
Diagnosis to brain metastases time (weeks)
Median (IR) 18 (4–40) 0 (0–26) 14 (0–36) 0.632b
a

Notes: Analysis of variance;

b

Kruskall–Wallis test.

Abbreviations: COPD, chronic obstructive pulmonary disease; IR, interquartile range; NSCLC, non-small cell lung cancer; SD, standard deviation.